| Preferred Name |
cinchonidine |
| Synonyms |
(8-alpha,9R)-Cinchonan-9-ol |
| ID |
http://purl.bioontology.org/ontology/MESH/C041622 |
| altLabel |
(8-alpha,9R)-Cinchonan-9-ol cinchonidine monohydrochloride cinchonidine hydrochloride cinchonidine sulfate(2:1) 2-Quinuclidinemethanol, alpha-4-quinolyl-5-vinyl- cinchonidine, (1beta,3alpha,4beta,8alpha,9R)-isomer |
| cui |
C0956403 C0956404 C0055736 C0956402 |
| HM |
D002930 |
| Inverse of RB |
1U622LRA8Z 40134-63-2 694B15YWQK 524-61-8 |
| Mapped to | |
| MDA |
19840705 |
| MeSH Frequency |
71 |
| MMR |
20160712 |
| notation |
C041622 |
| prefLabel |
cinchonidine |
| RR |
524-57-2 (cinchonidine monohydrochloride) 694B15YWQK 485-71-2 (cinchonidine) 40134-63-2 ((1beta,3alpha,4beta,8alpha,9R)-isomer) 524-61-8 (sulfate[2:1](8alpha,9R)-isomer) |
| SC |
1 |
| Scope Statement |
has antimalarial activity; diastereoisomer of cinchonine with distinct physiochemical properties; RN given refers to parent cpd(8alpha,9R)-isomer |
| SRC |
J Pharm Sci 1984;73(4):452 |
| TERMUI |
T555070 T351625 T153361 T351627 T000903684 T351626 |
| TH |
FDA SRS (2015) NLM (1984) FDA SRS (2013) NLM (2003) INN (19XX) |
| tui |
T109 T121 |